StockMarketWire.com - Allergy Therapeutics has obtained exclusive distribution rights in the UK and Ireland for the epinephrine pen auto injector, Anapen, for a payment of £600,000.

The agreement term is initially for five years from 1 November.

Anapen, produced by Lincoln Medical, is indicated for the treatment of anaphylactic shock.

Anaphylactic shock is a life threatening allergic reaction with increasing prevalence in all developed countries.

Anapen is the only epinephrine pen auto injector in the world with a 500 micrograms presentation.

The 500 microgram presentation is indicated for people weighing above 65kg, giving Anapen a strong competitive advantage.




Story provided by StockMarketWire.com